FDA.reportPublic FDA data

ATMEKSI 750 MG in 5 mL Oral Suspension

RxCUI
2729341
RxNorm name
ATMEKSI 750 MG in 5 mL Oral Suspension
Display name
ATMEKSI 750 MG in 5 mL Oral Suspension
Full name
ATMEKSI 750 MG in 5 mL Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ATMEKSIMETHOCARBAMOLRosemont Pharmaceuticals LLC62de7345-613b-4838-96e5-aceca3cea6b22026-03-13Warnings, Adverse reactionsExact identifier
rxcui: 2729341

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
62de7345-613b-4838-96e5-aceca3cea6b2ATMEKSI 750 MG in 5 mL Oral Suspension [PSN] · methocarbamol 150 MG/ML Oral Suspension [Atmeksi] [SBD] · Atmeksi 750 MG per 5 ML Oral Suspension [SY]33These highlights do not include all the information needed to use ATMEKSI® (methocarbamol) oral suspension safely and effectively. See full prescribing information for ATMEKSI (methocarbamol) oral suspension. ATMEKSI (methocarbamol) oral suspension Initial U.S. Approval: 05/07/201820260313